Potential Role of Bioactive Compounds of Purple Corn as Breast Cancer Drug Candidates Through Inhibition of Cyclin-Dependent Protein Kinase 6 (Cdk6): An In-Silico Approach

  • Home
  • Potential Role of Bioactive Compounds of Purple Corn as Breast Cancer Drug Candidates Through Inhibition of Cyclin-Dependent Protein Kinase 6 (Cdk6): An In-Silico Approach

Potential Role of Bioactive Compounds of Purple Corn as Breast Cancer Drug Candidates Through Inhibition of Cyclin-Dependent Protein Kinase 6 (Cdk6): An In-Silico Approach

1 Ayu Tri Agustin, 2 Amalia Wardatul Firdaus, 1 Anas Fadli Wijaya
1 Medical Laboratory Technology Study Program, Faculty of Health Sciences, Universitas dr. Soebandi, Indonesia, 68111

2 Study Program of Pharmacy, Faculty of Health Sciences, Universitas dr. Soebandi, Indonesia, 68111


 

ABSTRACT:

Cancer is characterized by disorderly cell proliferation. Upregulation and activation of the Cyclin-Dependent Protein Kinase 6 (CDK6) signalling pathway can induce uncontrolled proliferation of breast cancer cells. Therefore, inhibition of CDK6 persists to be developed as a target for the design and development of potential drugs to treat breast cancer. This study aims to predict the biofunction of anthocyanin compounds from purple corn extract as Cyclin- Dependent Protein Kinase 6 (CDK6) inhibitors in silico. The research methods used include data mining, ligand and receptor preparation, molecular docking, docking visualization, and data analysis. Our results show that six compounds of purple corn extract (cyanidin, cyanidin 3-glucoside, pelargonidin-3-glucoside, pelargonidin, peonidin, and peonidin-3-glucoside) can bind CDK6 at the C-terminal and N-terminal domains. The binding pattern indicated that cyanidin, cyanidin 3-glucoside, pelargonidin-3-glucoside, pelargonidin, peonidin, and peonidin-3-glucoside bind to the identical site CDK6 residues as Palbociclib (control). This finding indicated that compounds from purple corn are most likely competitive inhibitors of CDK6. Peonidin-3-glucoside showed the lowest binding energy of -282.5 kcal/mol, close to palbociclib (-329.4 kcal/mol). 

KEYWORDS :

anthocyanidins, anthocyanins, breast cancer, CDK6, palbociclib.


REFERENCES :

1) Du Q, Guo X, Wang M, Li Y, Sun X, Li Q. The application and prospect of CDK4/6 inhibitors in malignant solid tumors. J Hematol Oncol [Internet]. 2020 Dec 1;13(1):41. Available from:
https://jhoonline.biomedcentral.com/articles/10.1186/s13045-020- 00880-8
2) Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review. Cancers (Basel) [Internet]. 2021 Aug 25;13(17):4287. Available from: https://www.mdpi.com/2072-6694/13/17/4287
3) Khairani S, Keban SA, Afrianty M. Evaluation of Drug Side Effects Chemotherapy on Quality of Life (QOL) Breast Cancer Patients at Hospital X in Jakarta. J ILMU KEFARMASIAN Indones [Internet]. 2019 Apr 24;17(1):9. Available from: http://jifi.farmasi.univpancasila.ac.id/index.php/jifi/article/view/705
4) Heins MJ, de Ligt KM, Verloop J, Siesling S, Korevaar JC, Berendsen A, et al. Adverse health effects after breast cancer up to 14 years after diagnosis. The Breast [Internet]. 2022Feb;61:22–8.Available
from: https://linkinghub.elsevier.com/retrieve/pii/S0960977621010006
5) Pavlovic D, Niciforovic D, Papic D, Milojevic K, Markovic M. CDK4/6 inhibitors: basics, pros, and major cons in breast cancer treatment with specific regard to cardiotoxicity – a narrative review. Ther Adv Med Oncol [Internet]. 2023 Jan 11;15. Available from: http://journals.sagepub.com/doi/10.1177/17588359231205848
6) Folorunso SA, Abiodun OO, Abdus-salam AA, Wuraola FO. Evaluation of side effects and compliance to chemotherapy in breast cancer patients at a Nigerian tertiary hospital. Ecancermedicalscience [Internet]. 2023 Apr 21;17. Available from:
https://ecancer.org/en/journal/article/1537-evaluation-of-side-effects-and-compliance- to-chemotherapy-in-breast-cancer-patients-at-a-nigerian-tertiary-hospital
7) Moo TA, Sanford R, Dang C, Morrow M. Overview of Breast Cancer Therapy. PET Clin [Internet].
2018 Jul;13(3):339–54. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1556859818300270
8) Dickens E, Ahmed S. Principles of cancer treatment by chemotherapy. Surg [Internet].2018 Mar;36(3):134–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0263931917302673
9) Shrihastini V, Muthuramalingam P, Adarshan S, Sujitha M, Chen JT, Shin H, et al. Plant Derived Bioactive Compounds, Their Anti-Cancer Effects and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated Overview. Cancers (Basel) [Internet]. 2021 Dec 10;13(24):6222. Available from: https://www.mdpi.com/2072-6694/13/24/6222
10) Rabelo ACS, Guerreiro C de A, Shinzato VI, Ong TP, Noratto G. Anthocyanins Reduce Cell Invasion and Migration through Akt/mTOR Downregulation and Apoptosis Activation in Triple-Negative Breast Cancer Cells: A Systematic Review and Meta- Analysis. Cancers (Basel) [Internet]. 2023 Apr 14;15(8):2300. Available from: https://www.mdpi.com/2072-6694/15/8/2300
11) Fakhri S, Khodamorady M, Naseri M, Farzaei MH, Khan H. The ameliorating effects of anthocyanins on the cross-linked signaling pathways of cancer dysregulated metabolism. Pharmacol Res [Internet]. 2020 Sep;159:104895. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1043661820312032
12) Vilcacundo E, Montalvo V, Sanaguano H, Moran R, Carrillo W, García A. Identification of Phytochemical Compounds, Functional Properties and Antioxidant Activity of Germinated Purple Corn Protein Concentrate and Its Gastrointestinal Hydrolysates. Agronomy [Internet]. 2022 Sep 17;12(9):2217. Available from: https://www.mdpi.com/2073-4395/12/9/2217
13) Valenza A, Bonfanti C, Pasini ME, Bellosta P. Anthocyanins Function as Anti- Inflammatory Agents in a Drosophila Model for Adipose Tissue Macrophage Infiltration. Biomed Res Int [Internet]. 2018;2018:1–9. Available from: https://www.hindawi.com/journals/bmri/2018/6413172/
14) Suarni, Sulistyaningrum A, Aqil M. The utilization of young-harvested purple corn for dodol processed to support functional food diversification. IOP Conf Ser Earth Environ Sci [Internet]. 2021 Nov 1;911(1):012071. Available from: https://iopscience.iop.org/article/10.1088/1755-1315/911/1/012071
15) Vayupharp B, Laksanalamai V. Antioxidant Properties and Color Stability of Anthocyanin Purified Extracts from Thai Waxy Purple Corn Cob. J Food Nutr Res [Internet].2015;3(10):629–36.Available from: http://pubs.sciepub.com/jfnr/3/10/2/index.html
16) Tian X, Xin H, Paengkoum P, Paengkoum S, Ban C, Sorasak T. Effects of anthocyanin- rich purple corn (Zea mays L.) stover silage on nutrient utilization, rumen fermentation, plasma antioxidant capacity, and mammary gland gene expression in dairy goats. J Anim Sci. 2019;97(3):1384–97.
17) Ramos-Escudero F, Muñoz AM, Alvarado-Ortíz C, Alvarado Á, Yáñez JA. Purple corn (Zea mays L.) phenolic compounds profile and its assessment as an agent against oxidative stress in isolated mouse organs. J Med Food. 2012;15(2):206–15.
18) Long N, Suzuki S, Sato S, Naiki‐Ito A, Sakatani K, Shirai T, et al. Purple corn color inhibition of prostate carcinogenesis by targeting cell growth pathways. Cancer Sci [Internet]. 2013 Mar 20;104(3):298–303. Available from: https://onlinelibrary.wiley.com/doi/10.1111/cas.12078
19) Mazewski C, Liang K, Gonzalez de Mejia E. Inhibitory potential of anthocyanin-rich purple and red corn extracts on human colorectal cancer cell proliferation in vitro. J Funct Foods [Internet]. 2017 Jul;34:254–65. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1756464617302281
20) Goel S, Bergholz JS, Zhao JJ. Targeting CDK4 and CDK6 in cancer. Nat Rev Cancer [Internet]. 2022 Jun 18;22(6):356–72. Available from: https://www.nature.com/articles/s41568-022-00456-3
21) Niu Y, Xu J, Sun T. Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: Current Status, Resistance, and Combination Strategies. J Cancer [Internet]. 2019;10(22):5504–
17. Available from: http://www.jcancer.org/v10p5504.htm
22) Serra F, Lapidari P, Quaquarini E, Tagliaferri B, Sottotetti F, Palumbo R. Palbociclib in metastatic breast cancer: current evidence and real-life data. Drugs Context [Internet]. 2019 Jul 16;8:1–16. Available from: https://www.drugsincontext.com/palbociclib-in- metastatic-breast-cancer:-current-evidence-and-real-life-data/
23) Agustin AT, Safitri A, Fatchiyah F. An in Silico Approach Reveals the Potential Function of Cyanidin-3-o-glucoside of Red Rice in Inhibiting the Advanced Glycation End Products (AGES)-Receptor (RAGE) Signaling Pathway. Acta Inform Medica [Internet].2020;28(3):170–9.Availablefrom: http://dx.doi.org/10.5455/aim.2020.28.170-179
24) Tribudi YA, Agustin AT, Setyaningtyas DE, Gusmalawati D. Bioactive Compound Profile and Biological Modeling Reveals the Potential Role of Purified Methanolic Extract of Sweet Flag (Acorus calamus L.) in Inhibiting the Dengue Virus (DENV) NS3 Protease-Helicase. Indones J Chem. 2022;22(2):331–41.
25) Agustin AT, Imroatul Muflihah A, Muflihah I, Mufidah H, Riranto J. Molecular Docking Approach Reveals The Potential Role Of Psidium Guajava Leaf Extract Compounds As Quorum-Sensing Inhibitors Targeting Pseudomonas Aeruginosa’s Lasr. Int J Heal Med Res [Internet]. 2023 Dec 30;02(12). Available from: https://ijhmr.com/molecular-docking-approach-reveals-the-potential-role-of-psidium- guajava-leaf-extract-compounds-as-quorum-sensing-inhibitors-targeting- pseudomonas-aeruginosas-lasr/
26) Tadesse S, Yu M, Kumarasiri M, Le BT, Wang S. Targeting CDK6 in cancer: State of the art and new insights. Vol. 14, Cell Cycle. 2015. p. 3220–30.
27) Yousuf M, Shamsi A, Anjum F, Shafie A, Islam A, Haque QMR, et al. Effect of pH on the structure and function of cyclin-dependent kinase 6. PLoS One [Internet]. 2022;17(2 February):1–12. Available from: http://dx.doi.org/10.1371/journal.pone.0263693
28) Baig MH, Yousuf M, Khan MI, Khan I, Ahmad I, Alshahrani MY, et al. Investigating the Mechanism of Inhibition of Cyclin-Dependent Kinase 6 Inhibitory Potential by Selonsertib: Newer Insights Into Drug Repurposing. Front Oncol [Internet]. 2022 May 26;12.Available from: https://www.frontiersin.org/articles/10.3389/fonc.2022.865454/full
29) Corona SP, Generali D. Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer. Drug Des Devel Ther [Internet]. 2018 Feb;Volume 12:321–30. Available from:
https://www.dovepress.com/abemaciclib-a- cdk46-inhibitor-for-the-treatment-of-hrher2-advanced-bre-peer-reviewed-article- DDDT
30) Agustin AT, Julianto E, Julianus J, Riranto J. Potential Role of Betel Leaf (Piper betle Water Extract as Antibacterial Escherichia coli Through Inhibition of β-Ketoacyl- [Acyl Carrier Protein] Synthase I. Trop J Nat Prod Res. 2022;6(11):1802–8.

  • Share

Leave a Reply

Your email address will not be published. Required fields are marked *